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Staphylococcus pseudintermedius is an opportunistic bacterium affecting canines 
that has recently developed a high prevalence of methicillin resistance and 
corresponding multi-drug resistance. Developments of alternatives to antibiotics 
such as vaccines are important strategies for control of this organism.  
 
Multilocus sequence typing is based on the sequence variations of slowly 
evolving genes and usually uses a minimum of seven genes. Population genetic 
studies of S. pseudintermedius have been based on sequencing four genes 
(MLST-4). Forty-five genes were selected from available genomic data and 
tested as MLST candidates. Four genes were amplified from all isolates and 
showed the highest number of alleles. By adding four new genes to the existing 
ones, an MLST scheme based on 8 genes (MLST-8) was developed for S. 
pseudintermedius. MLST-8 was applied to 176 isolates of previously 
characterized S. pseudintermedius from dogs (165 isolates), cats (5 isolates) and 
humans (6 isolates). They were contained in 83 sequence types (STs). MLST-8 
identified 106 STs which indicated a high level of diversity of the species but also 
verified the clonal nature of methicillin resistant isolates. 
 
Five different STs of S. pseudintermedius were selected and reacted with serum 
samples from dogs with pyoderma and healthy control dogs to measure their 
immune reactivity. Significant differences in the IgG reactivity between the 
different genetic backgrounds of S. pseudintermedius were found, this variation 
should be considered in designing a vaccine for S. pseudintermedius. The 
reactivity of other staphylococcal species with canine pyoderma and healthy 
control sera showed that minor genetic differences may be associated with 
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The development of a staphylococcal vaccine is a challenging task in part due to 
genetic heterogeneity of the species. Broad understanding of the nature of the 
immune response to staphylococcal infections as well as correlation between 
genetic differences and pathogenesis might facilitate this task. Staphylococcus 
pseudintermedius is an important opportunist bacterium that frequently causes 
diseases in dogs and occasionally causes zoonotic infections to human beings 
[1-4]. It is commonly associated with canine pyoderma [5-7] and is also frequently 
associated with urinary tract, wound and surgical site infections [8-11]. Methicillin 
resistance in S. pseudintermedius has been reported with high prevalence in the 
last few years [7, 12-20]. Approximately 30% of the S. pseudintermedius isolates 
tested by the University of Tennessee College of Veterinary Medicine (UTCVM) 
Clinical Bacteriology Laboratory were methicillin-resistant [19, 20]. The 
importance of methicillin-resistant S. pseudintermedius (MRSP) in veterinary 
medicine compares to the importance of methicillin-resistant S. aureus (MRSA) 
in human medicine. 
 
S. pseudintermedius is a coagulase-positive bacterium that was first reported as 
a distinct species in 2005 [10].  It was originally identified as Staphylococcus 
intermedius prior to classification as a member of the S. intermedius group (SIG) 
[21], a group consisting of S. intermedius, S. delphini and S. pseudintermedius. 
The isolates were phenotypically similar to Staphylococcus intermedius and 
Staphylococcus delphini and 16s rRNA  gene sequence analysis  revealed that 
they have 99% similarity [10].The three species differentiated by using DNA–
DNA hybridizations, S. pseudintermedius strains had binding values of 38–46% 
with S. intermedius LMG 13351 and 54% with S. delphini DSM 20771. It was 
subsequently determined that most isolates phenotypically identified as S. 
intermedius from dogs were S. pseudintermedius [7, 22]. The genome of S. 
pseudintermedius is composed of a single circular chromosome ranging from 
2,572,216 bp to 2,617,381 bp and has an average G+C content of 37.6%, which 
is substantially higher than the 32% average of other staphylococci [23, 24]. 
 
Humoral immunity is an important arm of the acquired branch of the immune 
system in protection against extracellular bacterial infections. However, its role in 
immunity against staphylococcal infections is unclear. Some anti-staphylococcal 
antibody levels are associated with immunity to specific staphylococcal infections 
 
 2 
such as antibodies to the staphylococcal exoprotein TSST-1[25]. On the other 
hand, heterogeneous antibody responses have been found in both healthy 
individuals and patients with different S. aureus infections [26]. No commercial 
vaccines are available for staphylococcal infections. Immunity to S. 
pseudintermedius infections is poorly understood. In addition, the population 
genetics of S. pseudintermedius is not well characterized and there is a dearth of 
information relating antigenic variation with genetic background. 
 
S. pseudintermedius as a human pathogen 
 
S. pseudintermedius is considered a true pathogen of pet animals such as dogs 
and cats.  Considering the close social contacts between human and pet 
animals, it may cause diseases in human beings. S. pseudintermedius is 
occasionally isolated from healthy or infected human beings [2, 3, 27-30]. The 
occurrence of S. pseudintermedius in human infections is probably 
underestimated, because in some laboratories all coagulase-positive 
staphylococci are classified as S. aureus [31]. The first reported case of the 
isolation of S. intermedius from a human was in 1997 from a nasal swab from a 
woman with chronic renal insufficiency with no signs of infection [4]. Noninvasive 
zoonotic infection of S. intermedius was reported in [32], where S. intermedius 
was isolated from the ear fluid of a patient with otitis externa. Analysis of 16S 
ribosomal DNA restriction fragment length polymorphisms identified that S. 
intermedius in the patient and his pet dog were similar which indicated 
noninvasive zoonosis.  
 
S. pseudintermedius infection in human was reported in 2006 for an ischemic 
cardiomyopathy patient who received an implantable cardioverter-defibrillator 
(ICD). Infection in the ICD was suspected and the infected ICD was surgically 
removed. S. pseudintermedius was isolated from the samples taken from the 
ICD. The source of the isolate was not known nor is it known if the patient kept 
any pets [2]. Zoonotic potential of S. pseudintermedius was studied by 
Hanselman et al [33], S. pseudintermedius nasal colonization was in 4% of 
sampled humans and it was isolated from 46% of  dogs. Indistinguishable strains 
of S. pseudintermedius were found in 44% of households where both a dog and 
human were colonized which supports canine to human transmission [33]. A 
confirmed case of catheter-related bacteremia due to Staphylococcus 




Methicillin-resistant S. pseudintermedius (MRSP) with a specific genetic 
background known to be widely disseminated in European countries  (sequence 
type  71) was isolated from a human infection [28]. The prevalence of 
colonization of MRSP among small animal dermatologists attending a national 
veterinary conference was reported recently in Italy [35] where MRSP was found 
in 7 out of 128 veterinarians. The sampling was from nasal swabs and no 
methicillin-susceptible S. pseudintermedius (MSSP) was found. A follow-up study 
of two carriers revealed that MRSP persisted for at least 1 month in the nasal 
cavity. These results highlight the possibility of the transmission of S. 
pseudintermedius between pets and humans.  
 
 
The emergence of methicillin resistance in S. pseudintermedius 
 
Resistance to methicillin is mainly caused by the acquisition of new resistance 
genes and the mechanism by which this occurs is as yet unknown. The mecA 
gene encodes a penicillin-binding protein with reduced affinity for methicillin [17, 
36]. The mecA gene is contained within mobile genetic elements known as 
Staphylococcal Chromosome Cassette mec (SCCmec) elements [37]. In total, at 
least seven different SCCmec classes have been described for S. aureus, 
defined by the content of the regulatory gene region, the allotype of the 
recombinase genes ccrA and ccrB, and by the overall genetic structure [38]. 
SCCmec can be transferred between different staphylococcal species in vivo 
[39].In this report  mecA positive methicillin-resistant S aureus (MRSA) of a 
certain pulsed-field gel electrophoresis  genotype were isolated from a neonate 
who had never been in contact with MRSA. This MRSA contained mecA DNA 
with an identical PFGE profile to that in a coagulase-negative Staphylococcal 
strain isolated from the same patient, but different from other MRSA genotypes. 
These results suggest that the MRSA was formed in vivo by horizontal transfer of 
the mecA DNA between two staphylococcal species. The same mechanism may 
be found in S. pseudintermedius, however, information about the SCCmec donor 
as well as the genetic specifications of the SCCmec recipient is lacking. 
 
S. pseudintermedius SCCmec elements SCCmec II-III and SCCmec IV had 
previously been found in two different geographical locations. The first report of 
methicillin resistance in S. pseudintermedius confirmed by PCR detection of 
mecA occurred in 1999 from a single isolate in a survey of 25 staphylococcal 
isolates of canine origin [36]. Reported isolations of methicillin-resistant S. 
pseudintermedius (MRSP) have increased significantly in the past few years [7, 
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12-20]. Methicillin resistance in S. pseudintermedius is considered a significant 
problem worldwide because of multi-drug resistance and due to the limited 
number of drug choices remaining to treat serious infections caused by these 
organisms.     
    
Little is known about the spread of antibiotic resistance in S. pseudintermedius 
including rates of horizontal gene transfer. A recent study examined the antibiotic 
susceptibilities of 39 mecA positive isolates of Staphylococcus intermedius from 
animals, staff and environment in an animal hospital and determined the 
possibility of horizontal transmission between animals and humans. Similar 
genetic finger prints were observed between seven isolates from an animal, two 
isolates from veterinary staff, and the environment in one animal hospital, and 
single isolates from an animal and a veterinarian at another hospital which 
suggests the possibility of horizontal transmission of S. pseudintermedius 
containing mecA between humans, animals, and the environment in animal 
hospitals [40].  
Phenotypic and molecular Identification of S. pseudintermedius 
Differentiation between members of the SIG by phenotypic tests is difficult. S. 
intermedius can be differentiated from S. pseudintermedius by a combination of 
biochemical tests (arginine dihydrolase production, ß-gentiobiose fermentatio 
and D-mannitol fermentation). However, biochemical reactions do not reliably 
distinguish between S. pseudintermedius and S. delphini [22].  Commercial 
identification systems for the fast and correct identification of S. 
pseudintermedius are not available to date. S. pseudintermedius is a relatively 
newly recognized species and remains to be included in the databases of most 
systems.  
 
Biochemical markers of canine coagulase-positive staphylococci (CoPS) such as 
acetoin production, assimilation of maltose, galactose, trehalose, lactose and 
mannitol broth fermentation were evaluated recently by Chanchaithong [41] for 
the identification of S. pseudintermedius, S. schleiferi subsp. coagulans and S. 
aureus . They were successfully used to distinguish the three species of canine 
CoPS from other CoPS species. The results were compared with multiplex-PCR 
(M-PCR) and there was a good level of agreement with the result of M-PCR. 





In many cases isolates may be misidentified as S. intermedius or S. aureus [2]. 
In a case study reporting a postoperative sinusitis, a methicillin-resistant S. 
pseudintermedius was initially misidentified as MRSA because the identification 
as S. aureus was only based on a positive tube coagulase test [42]. The isolate 
was re-identified as S. intermedius but this isolate was most likely S. 
pseudintermedius because the source of the isolate was a dog.  
 
Molecular identification of S. pseudintermedius was first described in 2007 [21] 
based on partial sodA gene sequences and hsp60 gene sequences. 
Phylogenetic analysis was sufficiently discriminative for S. intermedius and S. 
pseudintermedius. In 2009 a polymerase chain reaction–restriction fragment 
length polymorphism (PCR-RFLP) method was developed based on MboI 
restriction of pta gene fragment [43]. This method is considered highly valuable 
especially when used with biochemical testing and sequencing of housekeeping 
genes. However, it misclassified a small fraction of the S. pseudintermedius 
population as a result of heterogeneity in the MboI restriction sites [44]. 
        
Genetic Typing of S. pseudintermedius 
 
The recent emergence of methicillin- resistant strains has increased the need for 
a reliable method for typing S. pseudintermedius. Bacterial typing is an essential 
application in modern microbiology studies for several reasons: enhancing 
outbreak investigations and surveillance, studies of the natural history of 
infection, and our understanding of the transmission, pathogenesis and 
phylogeny of bacteria. There are no standard protocols for molecular typing of S. 
pseudintermedius to date. 
 
Typing methods applied to S. pseudintermedius include staphylococcus protein A 
(spa) typing [45], pulsed field gel electrophoresis (PFGE) [7, 45, 46] and 
multilocus sequence typing (MLST) [7]. No one technique is optimal for all types 
of investigations. The choice of the typing method is based on the application or 
the research objectives. 
Pulsed-Field Gel Electrophoresis 
 
PFGE is a highly discriminatory whole genome typing method. It involves the use 
of restriction enzymes with few restriction sites to generate a limited number of 
high molecular-weight restriction fragments, depending on the number and 
location of restriction sites within the genome. These fragments are then 
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separated by agarose gel electrophoresis with programmed variations in both the 
direction and the duration of the pulsed field [47, 48]. The resulting 
electrophoretic patterns are highly specific for strains from a variety of organisms 
and also provide an opportunity to examine multiple variations throughout the 
genome of the organism so as to identify specific strains and accurately link them 
with disease outbreaks. Because the frequency of point mutations that can add 
or delete restriction sites is high, band patterns change relatively quickly through 
successive bacterial generations. Thus, PFGE is more useful in comparing 
isolates from a limited area over a short period of time such as isolates from a 
single hospital in an outbreak situation [6, 49, 50]. The main disadvantage of 
PFGE is the poor standardization for inter-laboratory comparison as the banding 
patterns vary greatly depending upon the agarose gel, power supply settings, 
and analysis software used.  Attempts to solve this problem with S. aureus have 
been made [47]. PFGE is not suitable for long-term epidemiological surveillance 
and it cannot be used for discrimination between members of the SIG group.  
 
Multilocus Variable Number Tandem Repeat Analysis (MLVA) 
 
 MLVA is a PCR method based on the analysis of the variation in the number of 
repeats in several genes. The  MLVA method was developed for S. aureus in 
2003 based on seven genes (sspA, spa, sdrC, sdrD, sdrE, clfA, and clfB) [51]. In 
MRSA studies MLVA was found to be comparable in discriminatory power with 
PFGE [52-55]. 
The minimal requirements for MLVA ensure low setup and operation costs, which 
may make this method a simple substitution for PFGE. Until now, MLVA has not 
been developed for S. pseudintermedius typing.  
 
Tandem repeat sequence analysis of staphylococcal protein A (spa) 
 
spa typing is a single-locus PCR based typing method based on tandem repeat 
sequence analysis of a highly polymorphic region of staphylococcal protein A 
(spa) gene. The spa typing protocol was first developed for S. aureus in 1996 
[56]. The study showed that the X-region of the protein A gene is sufficiently 
stable for epidemiological typing of MRSA and it is more sensitive than phage 
typing. The polymorphic region of the spa gene is classified based on small 
repeats and point mutations. Because it is a single locus typing method, spa 
typing may require validation by another method such as PFGE. The spa locus of 
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S. pseudintermedius was characterized [45] and is used for typing MRSP 
isolates together with other methods such as PFGE and MLST [49, 57] 
It is a simple, less time-consuming method than PFGE, and results of spa-typing 
can be compared between laboratories. 
 
Multi locus sequence typing (MLST) 
 
 Multilocus sequence typing (MLST) was first developed in 1998 [58, 59] as a 
general approach for typing bacteria. MLST is based on the sequence variation 
of internal fragments of about 450–500 bp from selected housekeeping genes. 
For each locus, the different sequences are assigned as alleles, and alleles at all 
sequenced loci provide a profile of an isolate which defines the sequence type.  
A distinct sequence type (ST) is made up of a unique combination of arbitrarily 
numbered alleles [60-65]. Measurement of bacterial genomic variation through 
time and over great distances is the main application of MLST. This method has 
been developed for diverse species of bacteria and generally uses at least seven 
loci [58, 61, 62, 66, 67]. The main advantage of MLST is its use of sequence data 
that is fully portable and can be stored in a single expanding central multilocus 
sequence database. It can be interrogated electronically via the Internet to 
produce a powerful resource for global epidemiology. MLST data can be used for 
the identification of lineages that have an increased propensity to cause disease 
as well as tracking of the genetic lineages with the highest levels of antibiotic 
resistance. 
 
MLST for S. aureus was developed using seven loci [62] and S. aureus STs are 
assigned by comparing sequence data for each locus to the MLST data base at 
http://saureus.mlst.net/. Application of MLST in a collection of blood isolates 
resulted in two major clusters, one containing only MSSA and the other only 
MRSA. These clusters are closely related (differing at only one of the seven loci), 
which suggests that the MRSA clone might have arisen from an MSSA clone that 
was associated with serious disease [61].  
 
A four gene loci MLST for SIG was developed. Housekeeping genes that have 
been used as targets in MLST of S. pseudintermedius include the 16S rRNA 
gene, heat shock protein gene (cpn60), elongation factor gene (tuf) phosphate 
acetyltransferase gene (pta) and accessory gene regulatory  (agrD) [7]. A 
minimum of seven genes are generally included in MLST schemes. Due to lack 
of sequence variations in conserved genes, it is unusual for an MLST scheme to 
include the 16S rRNA gene [7]. The addition of new genes to the existing S. 
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pseudintermedius MLST scheme will increase the discriminatory power 
equivalent to MLST used for other species in order to obtain better knowledge of 
S. pseudintermedius population genetics. 
.  
Staphylococcal Cassette Chromosome (SCCmec) Typing 
 
The large mobile genetic element (MGE), SCCmec, is characterize by the 
presence of two genetic components, mec complex which is responsible for the 
expression and the regulation of mecA gene (IS431mec, mecA gene, intact or 
truncated sets of regulatory genes mecR1 and mecI) and the ccr complex which 
encodes recombinase genes (ccr) which mediate the integration of SCCmec into 
and its excision from the recipient chromosome [68]. SCCmec typing can be 
used only for typing resistant isolates. There are at least five classes of mecA 
genes (A, B, C1, C2, and E) based on the sequence and completeness of the 
complex and five allotypes of ccr gene (ccrAB1, ccrAB2, ccrAB3, ccrAB4 and 
ccrC) in major MRSA lineages. Different combinations of these complex classes 
and allotypes generate various SCCmec types. Instead of the sequencing of the 
whole SCCmec for typing purposes, multiplex PCR schemes have been 
described, which amplifiy sequences specific to each mec and ccr region by 
SCCmec type [68, 69].   
 
By applying the methods used for MRSA SCCmec typing in S. pseudintermedius 
isolates, two major cassette types were identified in MRSP, SCCmec types II-III 
and VT in predominant clonal lineages ST 71 and ST 68 respectively [6, 49, 57] in 
addition to a third SCCmec type (type VII), identified in a single multidrug 
resistant isolate [37] 
 
Pathogenesis of S. pseudintermedius 
 
 An understanding of the molecular pathogenesis of S. pseudintermedius disease 
would facilitate the design of novel therapeutics for disease prevention. S. 
pseudintermedius produces enzymes involved in virulence such as coagulase, 
proteases and thermonuclease. A gene similar to staphylococcal protein A (spa) 
had been characterized recently [70]. The spa gene encodes  a cell wall protein 





S. pseudintermedius genomes contain numerous  putative virulence factor 
genes, including genes encoding disease causing toxins such as leukocidins, 
exotoxins, leukotoxins, exfoliative toxin, and hemolysins in addition to super 
antigens and adherence factors [23, 24]. Characterization of these factors and 
their association with pathogenicity would be instrumental in developing more-
effective strategies against S. pseudintermedius infections. 
 
Virulence gene expression in S. aureus and host colonization are controlled by 
the accessory gene regulator (agr) locus. The agr locus which is known as the 
quorum sensing system, allows the bacterial population to act as a single 
organism after a certain threshold concentration of molecules is produced by the 
bacteria. Some bacterial species including S. pseudintermedius use quorum 
sensing as a means to optimize virulence gene expression. The relationship 
between agr groups and human S. aureus diseases was investigated by studying 
198 S. aureus strains isolated from 14 asymptomatic carriers, 66 patients with 
suppurative infection, and 114 patients with acute toxemia [72] with 61 strains 
belonging to agr group I, 49 belonging to agr group II, 43 belonging to agr group 
III, and 45 belonging to group IV and it was found that agr group IV strains were 
associated with generalized exfoliative syndromes. 
 
DNA sequence analysis of the S. pseudintermedius agr locus revealed an 
operon with five open reading frames, agrB, agrD, agrC, agrA and hld, encoding 
a classic two component regulatory system with AgrD encoding an auto-inducing 
peptide (AIP), The S. pseudintermedius agr system encodes an unusual AIP with 
a partially cyclic structure which is different from the AIP known in S. aureus [73, 
74]. By comparing the sequence of the AIPs of S. pseudintermedius, it was found 
that the species has at least four different AIP peptides alleles [7]. The alleles 
were found to be shared among the members of the SIG. The inhibition of the 
agr system was proposed as a mechanism of the control of staphylococcal 
infections [75]; however, more research in the mechanisms of virulence is 
required. The therapeutic agents targeting the quorum sensing system are 
known as anti-pathogenic drugs and they showed some success especially for 
Gram-negative bacteria [76, 77]. In a recent study of quorum sensing inhibition 
activity of 168 plant extracts through the quantification of the delta-hemolysin 
toxin of a pathogenic isolate of methicillin-resistant S. aureus MRSA, it was found 
that extracts from three plants exhibited a dose-dependent response in the 
production of delta-hemolysin, indicating quorum sensing inhibition activity in an 




Colonization and Immunity against Staphylococcal infections 
 
The genus Staphylococcus which consists of at least 44 species is considered 
part of the natural skin flora of most mammalian species. Most of the species 
demonstrate host specificity and some species even demonstrate niche 
specificity on their particular hosts. It is known that normal flora has an important 
role in developing a functional mucosal immune system. There are several 
mechanisms that help staphylococci colonize the host skin surfaces. For 
example, S. aureus produces several surface proteins, including clumping factor 
B, promote adhesion to squamous cells in vitro. Clumping factor B binds to 
cytokeratin 10 which is a major surface protein of squamous cells [79]. S. 
pseudintermedius strains can adhere to immobilized human cytokeratin 10 
suggesting that colonization of canine skin might involve similar interactions to 
those of S. aureus [80]. spsD and spsL, cell wall-associated (CWA) proteins of S. 
pseudintermedius, mediate binding to heterologous hosts. spsD mediated 
binding to cytokeratin 10. IgG specific for spsD and spsL were identified in sera 
from dogs with bacterial pyoderma implying that the proteins are both expressed 
during infection [81, 82]. 
 
Bacterial infections are the result of complex interactions between invading 
bacteria and host defense mechanisms. Innate immunity against Staphylococci is 
mainly mediated by neutrophils. The immune mechanisms underlying the host 
genetic predisposition to severe S. aureus infection in different mouse strains 
was studied recently [83], where mice were inoculated with S. aureus. The 
outcome of the infection was significantly different between the breeds. C57BL/6 
mice were the most resistant and BALB/c mice were highly susceptible to S. 
aureus infection in terms of bacterial growth and survival. Neutrophil depleted 
C57BL/6 mice became completely susceptible to S. aureus, indicating that 
neutrophils are essential for resistance to infection. 
 
The role of the humoral immune response to staphylococcal infections is not fully 
clear The IgG response to some staphylococcal antigens were protective in 
some cases [25, 84, 85]; however, a high titer of IgG against some 
staphylococcal antigens was not protective in other cases [26, 86]. The 
heterogeneity of the IgG response against staphylococcal infections most 
probably was affected by the genetic backgrounds of the disease causing strains 
and the variability of surface proteins expression. This variability should be 




The relationship between genetic background of S. aureus isolates, agr alleles in 
particular and disease outcome was investigated previously [72] in S. aureus and 
it was shown that a specific agr group was associated with generalized 
exfoliative syndromes. However, questions about the immune response to the 
different genetic backgrounds in a single species remain to be determined.   
 
Vaccines for Staphylococci infection 
 
Because of wide spread antibiotic resistance in the genus staphylococci, the 
number of effective antibiotics to treat staphylococcal infections has become 
limited. The search for alternative strategies to efficiently combat staphylococcal 
infections is urgently needed. Immunological strategies based on vaccine 
development or therapeutic antibodies may have significant roles in the control of 
staphylococcal infections [87]. Vaccines are considered one of the most 
promising approaches especially with the breakthrough of next generation 
sequencing applications which provide novel methods for selecting antigens. 
Most vaccine targets are directed against surface components of staphylococci 
[88, 89] or soluble virulence determinants such as alpha-toxin, Panton-Valentine 
leukocidins, or superantigenic enterotoxins [90-93].  
 
Bioinformatics has made it possible to identify specific groups of proteins in a 
short time by replacing several experimental tasks using in silico prediction steps. 
This way of finding novel antigens has been called reverse vaccinology [94]. This 
method helped in the development of a vaccine for serogroup B Neisseria 
meningitidis. Similar studies have been made to develop a staphylococcal 
vaccine [89, 90, 95, 96]. They target both active and passive immunization, those 
including capsular polysaccharide-based vaccine [88], human immunoglobulin G 
( IgG) with elevated levels of antibodies to the staphylococcal fibrinogen-binding 
proteins clfA and sdrG [84] and exotoxoids [92]. However, a number of 
unresolved issues in vaccine development relating to optimal antigenic target 
identification, criteria for acceptable efficacy, identification of target population, 
optimal timing of immunization strategy, storage and cost still need to be 
elucidated. 
 
For S. pseudintermedius, the availability of two genome sequences [23, 24] has 
made it easier to screen for antigenic targets especially secreted and surface 
exposed proteins. Future research in our laboratory involves characterization of 
selected S. pseudintermedius virulence factors and their suitability as vaccine 






The goal of this doctoral project is to improve the understanding of the population 
genetics and the immune response to S. pseudintermedius. The main application 
of MLST is studying population genetics and global epidemiology of bacterial and 
fungal species. We hypothesize that an expansion of the existing MLST method 
for S. pseudintermedius by the addition of four gene loci will provide a 
discriminatory typing scheme to identify the different genetic lineages of S. 
pseudintermedius.  
 
The immune response to S. pseudintermedius is largely unexplored area of 
research. An understanding of S. pseudintermedius pathogenesis and the nature 
of the immune response may facilitate the development of new therapeutics for 
this pathogen. We hypothesize that the IgG response against S. 
pseudintermedius is necessary for the control of the infection. This response may 
be affected by the genetic differences between isolates and may be similar to the 
response to other staphylococcal species. Our first step is developing a reliable 
multilocus sequence typing scheme based on 8 genes and the application of the 
new scheme to a large number of diverse isolates. After the analysis of the 
genetic diversity of S. pseudintermedius isolates, our next step is choosing 
genetically diverse isolates to study the immune response using sera from 
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Staphylococcus pseudintermedius has become a newly emerging methicillin-
resistant pathogen. There is limited information about the population genetic 
structure within this species. Foundational studies of the Staphylococcus 
intermedius group examined allelic polymorphisms in four genes. In this study, 
four additional slowly evolving genes with allelic polymorphisms were identified 
from numerous candidates and were included in a multilocus sequence typing 
(MLST) scheme. Application of the new, eight-gene MLST method to a total of 
176 diverse S. pseudintermedius isolates identified 106 different sequence types 
(STs). This represents an additional 23 sequence types beyond those identified 
previously. Most methicillin-resistant S. pseudintermedius (MRSP) isolates were 
further subdivided to new STs. The expanded MLST scheme should be more 
discriminating, give new insight into the epidemiology and the evolution of the 





Methicillin resistance was first described in SIG in 1999 [36]. Since then the 
incidence of MRSP has increased dramatically in some regions [6, 20, 97]. 
Methicillin-resistant S. pseudintermedius (MRSP) are of particular concern 
because they typically have resistance to multiple classes of antibiotics and due 
to the limited number of drug choices remaining to treat serious infections caused 
by these organisms[12, 20, 97]. Little is known about the spread of antibiotic 
resistance in S. pseudintermedius including the rates of horizontal transmission 
and spread of clonal populations of resistant strains.  A subspecies typing 
method with high discrimination should help to elucidate the origin, spatial spread 
of MRSP, and transmission of antibiotic resistance to susceptible strains.  
Mulltilocus phylogentic analysis based on four alleles has provided insight into 
the genetic structure of the SIG [7]. MLST was developed in 1998 [58, 59] as a 
general approach for typing bacteria based on the sequence variation of slowly 
evolving genes. MLST provides accurate, portable data useful for global 
epidemiology studies and studies of evolution and population biology [60-65]. 
MLST techniques have been developed for diverse species of bacteria and 
generally use at least seven alleles [58, 61, 62, 66, 67].  The development of a 
MLST method for S. pseudintermedius was undertaken to extend our knowledge 
of S. pseudintermedius population genetics and provide a typing method with 
discriminating power equivalent to those used for other species. 
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In this study an eight-gene MLST method was developed for subspecies 
characterization of S. pseudintermedius. Provisional observations suggest that 
methicillin resistance has been acquired by horizontal gene transfer in this 
species and that recipient strains have continued to evolve into new sequence 
types. 
 
Materials and Methods 
 
Bacterial strains and DNA extraction 
 
DNA extracts from 176 previously characterized isolates of S. pseudintermedius 
from dogs (165 isolates), cats (5 isolates) and human beings (6 isolates) [6, 7, 
57] were used in this study, Based on previous studies 82 were methicillin-
resistant and 94 were methicillin-susceptible [6, 7, 57]. The isolates were from 11 
countries. They belonged to 83 different STs based on MLST-4 [98],  9 of which 
included different lineages of MRSP. DNA was extracted from overnight cultures, 
that had been grown at 37°C on blood agar plates, using either commercial DNA 
extraction Kits [7, 57] or glass bead extraction. For the latter, bacteria derived 
from a single colony were suspended in 0.5 ml of 1M Tris EDTA buffer pH 7.5, 
mixed with an equal volume of glass beads and subjected to pulsed vortexing for 
5 min for cell disruption and DNA release. Supernatant of this mixture was stored 
at -20° C and used as template in PCR assays.  
 
Selection and screening of genes for potential use in MLST 
 
Sequences encoding open reading frames were identified from contiguous sequences 
obtained using next generation sequencing technology (Vanderbilt University, Genome 
Technology Core (Illumina technology) and the University of Florida Interdisciplinary 
Center for Biotechnology Research (Roche 454 technology) with genomic DNA isolated 
from S. pseudintermedius isolate 06.3228 (canine isolate from Tennessee, USA). 
Staphylococcus aureus genome sequences available in GenBank (accession number 
CP000255, CP000732, CP000253, CP000730, AP009324, AP009351, CP000736 and 
CP000045) were aligned using the BLASTN algorithm [99] with the National Center for 
Biotechnology Information (NCBI) online resource and used as a reference to predict 
which S. pseudintermedius genes were most likely to have polymorphic sites. Candidate 
genes were chosen for testing using PCR primers designed with the Primer 3 plus 
program [100] and obtained commercially (Integrated DNA Technologies). A panel of 15 
S. pseudintermedius isolates with different genetic backgrounds was used for allele 
selection.  PCR products, when obtained from all isolates, were sequenced and MLST 
targets were selected based upon the greatest number of alleles. These included loci 
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contained within adenylosuccinate synthetase (purA), formate dehydrogenase (fdh), 
perfringolysin O regulatory protein (pfoR) and sodium: sulfate symporter (sar) genes 
(Table 1). 
 
PCR amplification of gene fragments and sequencing 
 
A thermal cycling protocol for PCR amplification of 8 loci including cpn 60, tuf, pta 
and agrD was developed. The PCR reaction consisted of initial denaturation at 
95°C for 90 seconds, followed by 35 cycles of annealing for 30 seconds at 52°C, 
extension for 1 min at 72°C, denaturation for 30 seconds at 94°C, then annealing 
at 52°C for 30 seconds and a final extension at 72°C for 5 min. A 2x mastermix 
containing rTaq polymerase (Takara, USA) was used to establish the optimal 
amplification conditions.  
 PCR products were resolved and visualized by electrophoresis in gels 
containing 1.4% agarose and 0.5 µg/ml ethidium bromide. Products of expected 
sizes were treated to destroy single-stranded DNA (ExoSap-IT, USB Corp., 
Cleveland, OH) and sequenced at The University of Tennessee Molecular 
Biology Resource Facility (Knoxville, TN) or Baseclear (Leiden, the Netherlands).  
 
DNA Sequence Analysis 
 
Sequences were analyzed using the commercial software packages Lasergene 
(DNAStar, Wisconsin, USA) and Bionumerics vs. 6.1 (Applied Maths, Belgium). 
The loci in the extended panel, presented relative to reference genes (and their 
GenBank accession numbers), were: purA: 568 bp – 968 bp (JF275101), fdh: 
888bp - 1236 bp (JF275100), pfoR: 248 bp – 641 bp (JF275102), and sar: 246 
bp – 683 bp (JF275103). Table 2.5A showed the trimming sequence for the 4 
genes. The MLST data set was used to construct a minimum spanning tree 
(MST) using Bionumerics software. A single, unique, ST was used to represent 





Four of forty-five candidate genes fulfilled criteria for inclusion in a MLST scheme and 
produced the greatest number of alleles. These included adenylosuccinate synthetase 
gene purA, formate dehydrogenase gene fdh, sodium: sulfate symporter gene sar and 
perfringolysin O regulatory gene pfoR. The purA gene sequences had 11 polymorphic 
sites and 20 different alleles were detected among the tested isolates (Figure 1 and 
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table 2.1A). All predicted amino acid sequences were identical except for two amino acid 
substitutions in allele 11 and one amino acid substitution in allele 15. Five polymorphic 
sites were detected in fdh, all encoding the same amino acids. The polymorphisms 
yielded 5 different alleles, three of which occurred in MRSP. fdh allele 1 predominated 
and was present in both susceptible and resistant isolates (Figure 2 and table 2.2A). For 
the pfoR gene 10 polymorphic sites and 14 different alleles were identified. Seven pfoR 
alleles occurred in both MRSP and MSSP isolates (Figure 4 and table 2.3A). All 
encoded amino acids were the same except allele 6 and allele 11 which contained stop 
codons. Eight polymorphic sites were detected in the sar gene resulting in 8 alleles 
(Figure 3 and table 2.4A). All were silent substitutions except one that creates an alanine 
to threonine amino acid change in the deduced amino acid sequence. MRSP isolates 
shared only three sar alleles (Table 3 and figure 4), and alleles 1 and 2 were highly 
represented among both susceptible and resistant isolates.  
 
Using the eight gene MLST, 106 STs were detected. Allelic polymorphisms were 
identified for all seven MRSP tested for which more than one sample was available 
except ST 71 and MRSP were contained within each major phylogenetic lineage for 
each allele (Figures 1-4). 
 
With the expanded MLST scheme 3 feline isolates had unique STs. ST 5 was previously 
identified from both canine and feline samples, however, the expanded MLST method 
identified six differences out of eight loci between isolates from the two hosts. Likewise, 
ST 19, the one non-unique human ST, differed at three loci compared to its ST 19 
canine counterpart when the expanded method was applied. All six samples included in 
the study from Japan had unique STs with the 8 loci scheme including 2 that were newly 
discriminated. Isolates that had identical STs among previously determined United 
States STs 15, 17, 19, 26, 39, and 61 but were from different geographic origins, were 
distinguished when the 8 loci typing scheme was used. It did not discriminate between 
ST 71s from feline and canine origin or from various geographic regions. 
MST analysis (Figure 5) formed four major branches radiating from ST 26 with methicillin 
resistant STs on three of the branches. Isolates from the United States and Europe were 
present on all branches. There was no apparent clustering of STs from different host 














Table 2.1: Primers used for PCR amplification 
 
Gene locus Primer 5’- 3’ position Primer Sequence product size 
Adenylosuccinate 
synthetase purA 
purA Forward 505 bp GATTACTTCCAAGGTATGTTT 
490 bp 
 purA Reverse 995 bp TCGATAGAGTTAATAGATAAGTC 
Formate 
dehydrogenase fdh 
fdh Forward 878 bp TGCGATAACAGGATGTGCTT 
408 bp 




pfoR Forward 193 bp ATCGTCGCTTTACGGTCACCT 
447 bp 
 pfoR Reverse 678 bp GCTGCAGCGGGTCTGACG 
Sodium: sulfate 
symporter sar  
sar Forward 184 bp GGATTTAGTCCAGTTCAAAATTT 
521 bp 
 sar Reverse 705 bp GAACCATTCGCCCCATGAA 














































1, 16 2 1, 5    2 2 5, 5.5 
26 5, 13 2 2, 3 1, 5 7 
26, 26.1, 26.2, 
26.3 
29 2, 17 2, 1 1, 2, 4 1, 2 7 29, 29.1, 29.2 
68 1,5 1,2 1, 5 1 46 68, 68.1, 68.2 
69 1 3 5 1 1 69 
71 1 1 6 2 18 71 
100 1, 4 2, 3 5, 10 1 2 100.1, 100.2 
105 2 2 2 1 1 105 






















Figure 2.1. Phylogenetic tree of purA alleles constructed with the megAlign 
function of the software packages Lasergene (DNAStar, Wisconsin, USA) based 
on the sequence data of the purA gene. One thousand bootstrap replicates were 






























Figure 2.2. Phylogenetic tree of fdh alleles constructed with the megAlign 
function of the software packages Lasergene (DNAStar, Wisconsin, USA) based 
on the sequence data of the fdh gene. Methicillin resistant alleles MR distribute in 
each lineage. One thousand bootstrap replicates were used to determine the 

































Figure 2.3. Phylogenetic tree based on the sequence data of the sar gene 
showing 3 methicillin resistant alleles out of 8 alleles. One thousand bootstrap 






















Figure 2.4. Phylogenetic tree based on the sequence data of the pfoR gene 
showing 14 alleles and the methicillin-resistant alleles represented in each 
lineage. Eighty seven bootstrap value between allele 11 and allele 6 indicates the 





























Figure 2.5.  Minimum spanning tree of MLST data. Sequence types are represented by 
numbers. Methicillin-resistant isolates have an “R” prefix and the country of origin is 
represented with an extension of US (United States), IT (Italy), BCH (Switzerland), SUK 
(Scotland), EUK (England), FR (France), JP (Japan), CA (Canada), or SW (Sweden). ST 
71 was isolated from multiple locations including Germany, Sweden, The United States, 
Italy, Switzerland, and The Netherlands. Single locus variant STs are connected by a 
thick line, double locus variants by an intermediate line, triple locus variants by a thin 
line, variants that differ by four loci with a dashed line, and STs that vary by more than 4 
loci by a dotted line. 
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Table 2.3: Distribution of Staphylococcus pseudintermedius sequence types 
using MLST-8 with isolates from different hosts and geographic origins. 
 
     MLST-8 
     MLST-4 (Bannoehr et al. 2007) New alleles(this study) 
 Strain Host 
Geographical 
Origin ST tuf cpn60 pta agrD purA Fdh pfoR sar 
1 ED 99 Canine Scot. UK 2 1 9 1 1 1 2 4 1 
2 95-062295 Canine USA, TN 2.1 1 9 1 1 8 3 14 4 
3 M 1351/03 Canine Scot.UK 3 2 7 18 2 1 2 3 1 
4 M407/03 Canine Scot.UK 4 1 11 1 3 8 2 3 1 
5 M 1332/03 Canine Scot.UK 5 1 2 1 2 1 2 1 2 
6 3414 Feline Eng.UK 5.1 1 2 1 2 16 2 5 2 
7 M 695/99 Canine Scot, UK 6 2 9 1 1 8 4 12 1 
8 M 741/99 Canine Scot.UK 7 1 13 1 3 8 2 13 6 
9 M 1337/03 Canine Scot.UK 8 1 21 2 2 7 3 1 4 
10 M1333/03 Canine Scot.UK 9 2 7 1 2 1 2 2 1 
11 M707/99 Canine Scot.UK 10 2 2 4 1 7 2 3 1 
12 M 721/99 Canine Scot.UK 11 2 3 1 3 4 2 2 1 
13 HT20030683 Canine France 15 2 6 1 2 15 1 5 1 
14 08.1988b Canine USA, TN 15.1 2 6 1 2 4 1 4 1 
15 HT20030684 Canine France 16 2 7 8 1 14 2 2 1 
16 HT20030685 Canine France 17 2 6 4 1 4 4 1 1 
17 6.3096 Canine USA, TN 17.1 2 6 4 1 8 3 7 1 
18 HT20030686 Canine France 18 2 2 4 2 13 2 5 1 
19 M 449/ 06 Canine Scot.UK 19 2 8 1 2 1 2 1 1 
20 N 900260 Human France 19.1 2 8 1 2 1 2 3 2 
21 08.1752a Canine USA, TN 19.2 2 8 1 2 4 1 8 2 
22 N 910/201 Human France 20 1 2 1 1 4 4 3 2 
23 N940276 Human France 21 2 7 2 3 20 2 3 8 
24 N940453 Human France 22 2 7 4 2 7 4 5 2 
25 LY19990344 Human France 23 9 6 1 3 8 4 3 7 
26 AV 8001 Canine Japan 24 2 9 1 2 13 1 3 5 
27 M575/06 Canine Scot.UK 24.1 2 9 1 2 1 4 1 1 
28 AV 8002 Canine Japan 25 2 7 2 2 4 3 3 1 
29 NA 4 Canine USA, TX 26 2 10 1 4 5 2 2 1 
30 NA 45 Canine USA, WI 26 2 10 1 4 5 2 2 1 




Table 2.3. Continued 
           MLST-8 




ST tuf cpn60 pta agrD purA Fdh pfoR sar 
Origin 
32 NA 49 Canine USA, WI 26 2 10 1 4 5 2 2 1 
33 AV 8012 Canine Japan 26.1 2 10 1 4 13 2 2 5 
34 NA 3 Canine USA, TX 26.2 2 10 1 4 5 2 2 5 
35 NA 43 Canine USA, WI 26.3 2 10 1 4 5 2 3 1 
36 AV 8010 Canine Japan 27 1 11 1 2 8 1 3 4 
37 AV 8024 Canine Japan 28 2 7 1 1 13 4 3 2 
38 3279 Canine Eng. UK 29 2 2 1 1 2 2 2 1 
39 2.09E+11 Canine Netherland 29 2 2 1 1 2 2 2 1 
40 V08016361 Canine Netherland 29 2 2 1 1 2 2 2 1 
41 2.09E+09 Canine Netherland 29 2 2 1 1 2 2 2 1 
42 AV 8033 Canine Japan 29.1 2 2 1 1 17 2 1 2 
43 2.08E+11 Canine Netherland 29.2 2 2 1 1 2 2 4 2 
44 96022396 Feline USA 33 2 2 1 3 13 1 2 1 
45 93071493 Canine USA 34 1 13 11 1 14 2 3 2 
46 94060294 Canine USA 35 1 2 12 3 19 2 2 1 
47 94-062394 Canine USA 36 1 9 1 4 7 1 9 4 
48 94072/594 Canine USA 37 1 2 2 1 4 2 1 3 
49 95011195 Canine USA 38 5 13 11 4 7 2 4 1 
50 95062/195 Canine USA 39 1 7 1 2 5 4 4 1 
51 8193 Canine Eng.UK 39 1 7 1 2 5 4 4 1 
52 95072195 Canine USA 39.1 1 7 1 2 5 2 3 4 
53 96022/296 Canine USA 40 1 7 1 1 5 2 1 1 
54 96 030 796 Canine USA 41 1 13 1 2 4 2 3 1 
55 96-032996 Canine USA 42 1 2 2 3 4 2 4 1 
56 96041096 Canine USA 43 1 14 1 4 3 5 2 5 
57 M 543/ 06 Canine Scot.UK 44 1 2 1 3 1 3 8 1 
58 BH 47 Canine Canada 45 1 7 8 3 14 2 2 1 
59 M629/06 Canine Scot.UK 45.1 1 7 8 3 1 4 2 1 
60 M657/06 Canine Scot.UK 46 2 15 4 3 8 2 2 1 
61 8016 Canine Eng.UK 47 1 16 1 4 5 2 2 1 
62 8185 Canine Eng. UK 51 2 8 4 4 1 2 3 1 
63 388 Canine Eng. UK 52 2 18 4 3 2 1 1 1 
64 9075 Canine Eng.UK 53 2 19 4 4 13 4 2 4 
65 9162 Canine Eng. UK 54 2 9 4 1 1 2 3 1 
66 690 Feline Eng.UK 55 1 8 5 4 3 1 3 2 
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Table 2.3. Continued 
    MLST-8 




ST tuf cpn60 pta agrD purA Fdh pfoR sar 
Origin 
67 8239 Canine Eng.UK 56 1 2 7 1 3 2 1 1 
68 8478 Canine Eng.UK 57 1 2 2 4 4 2 8 1 
69 3708 Canine Eng, UK 58 2 9 2 1 4 4 1 5 
70 129Ab Canine Netherland 58.1 2 9 2 1 2 6 -5 1 
71 4229 Canine Eng.UK 59 1 2 2 3 18 3 1 1 
72 2431 Canine Eng.UK 60 1 9 3 1 3 3 4 4 
73 9318 Canine Eng.UK 61 1 20 1 1 3 2 5 1 
74 8.153 Canine USA, TN 61.1 1 20 1 1 7 1 3 1 
75 8639 Canine Eng.UK 62 1 3 1 1 7 2 3 2 
76 BH 04 Canine Canada 66 1 7 4 2 1 2 3 2 
77 BH 34 Feline Canada 67 1 27 2 2 3 1 2 1 
78 Can 5 Canine USA,  68 1 10 4 3 1 1 1 1 
79 M06-13 Canine USA 68 1 10 4 3 1 1 1 1 
80 6.1041 Canine USA, TN 68 1 10 4 3 1 1 1 1 
81 6.1065 Canine USA, TN 68 1 10 4 3 1 1 1 1 
82 6.1164 Canine USA, TN  68 1 10 4 3 1 1 1 1 
83 6.14 Canine USA, TN 68 1 10 4 3 1 1 1 1 
84 6.146 Canine USA, TN 68 1 10 4 3 1 1 1 1 
85 6.255 Canine USA, TN 68 1 10 4 3 1 1 1 1 
86 6.2584 Canine USA, TN 68 1 10 4 3 1 1 1 1 
87 6.3187 Canine USA, TN 68 1 10 4 3 1 1 1 1 
88 06.4364a Canine USA, TN 68 1 10 4 3 1 1 1 1 
89 06.4899e   Canine USA, TN 68 1 10 4 3 1 1 1 1 
90 6.632 Canine USA, TN 68 1 10 4 3 1 1 1 1 
91 6.815 Canine USA, TN 68 1 10 4 3 1 1 1 1 
92 6.3228 Canine USA, TN 68 1 10 4 3 1 1 1 1 
93 07.1605a Canine USA, TN 68 1 10 4 3 1 1 1 1 
94 7.297 Canine USA, TN 68 1 10 4 3 1 1 1 1 
95 07.372a Canine USA, TN 68 1 10 4 3 1 1 1 1 
96 07.425a Canine USA, TN 68 1 10 4 3 1 1 1 1 
97 7.5662 Canine USA, TN 68 1 10 4 3 1 1 1 1 
98 7.5781 Canine USA, TN 68 1 10 4 3 1 1 1 1 
99 7.5987 Canine USA, TN 68 1 10 4 3 1 1 1 1 
100 07.603a Canine USA, TN 68 1 10 4 3 1 1 1 1 
101 07.617a Canine USA, TN 68 1 10 4 3 1 1 1 1 
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Table 2.3. Continued 
    
MLST-8 




ST tuf cpn60 pta agrD purA Fdh pfoR sar 
Origin 
102 7.6388 Canine USA, TN 68 1 10 4 3 1 1 1 1 
103 7.547 Canine USA, TN 68 1 10 4 3 1 1 1 1 
104 8.128 Canine USA, TN 68 1 10 4 3 1 1 1 1 
105 8.22 Canine USA, TN 68 1 10 4 3 1 1 1 1 
106 8.324 Canine USA, TN 68 1 10 4 3 1 1 1 1 
107 8.355 Canine USA, TN 68 1 10 4 3 1 1 1 1 
108 8.36 Canine USA, TN 68 1 10 4 3 1 1 1 1 
109 08.39a Canine USA, TN 68 1 10 4 3 1 1 1 1 
110 8.494 Canine USA, TN 68 1 10 4 3 1 1 1 1 
111 8.511 Canine USA, TN 68 1 10 4 3 1 1 1 1 
112 08.521a   Canine USA, TN 68 1 10 4 3 1 1 1 1 
113 8.1043 Canine USA, TN 68 1 10 4 3 1 1 1 1 
114 8.1294 Canine USA, TN 68 1 10 4 3 1 1 1 1 
115 NA 37 Canine USA, NC 68 1 10 4 3 1 1 1 1 
116 NA 64 Canine USA, CA 68 1 10 4 3 1 1 1 1 
117 NA 50 Canine USA, WI 68 1 10 4 3 1 1 1 1 
118 NA 10 Canine USA, TX 68 1 10 4 3 1 1 1 1 
119 NA 27 Canine USA, WA 68 1 10 4 3 1 1 1 1 
120 NA 24 Canine USA, NC 68 1 10 4 3 1 1 1 1 
121 Sp80 Canine Netherland 68 1 10 4 3 1 1 1 1 
122 NA 127 Canine USA, GA 68 1 10 4 3 1 1 1 1 
123 NA 133 Canine USA, NJ 68 1 10 4 3 1 1 1 1 
124 07.676 C Canine USA, TN 68.1 1 10 4 3 1 2 5 1 
125 08.547a   Canine USA, TN 68.2 1 10 4 3 5 1 1 1 
126 13 Canine Sweden 69 1 25 1 1 1 3 5 1 
127 Can 10 Canine USA 70 1 7 1 3 13 1 3 1 
128 HH4 Feline Germany 71 1 9 2 1 1 1 6 2 
129 7577-06 Canine Sweden 71 1 9 2 1 1 1 6 2 
130 Gil 1 Canine Germany 71 1 9 2 1 1 1 6 2 
131 BD19698-06 Canine Sweden 71 1 9 2 1 1 1 6 2 
132 HH1 Canine Germany 71 1 9 2 1 1 1 6 2 
133 8.1661 Canine USA, TN 71 1 9 2 1 1 1 6 2 
134 08.3174d Canine USA, TN 71 1 9 2 1 1 1 6 2 
135 E 34 Canine Italy 71 1 9 2 1 1 1 6 2 
136 E 36 Canine Italy 71 1 9 2 1 1 1 6 2 
137 NA  18 Canine USA, CA 71 1 9 2 1 1 1 6 2 
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Table 2.3. Continued 
    
MLST-8 




ST tuf cpn60 pta agrD purA Fdh pfoR sar 
Origin 
138 E 42 Canine Italy 71 1 9 2 1 1 1 6 2 
139 KM1381 Canine Switzerland 71 1 9 2 1 1 1 6 2 
140 IMD07824 Canine Switzerland 71 1 9 2 1 1 1 6 2 
141 NA 126 Canine USA, FL 71 1 9 2 1 1 1 6 2 
142 BH 01 Canine Canada 72 2 26 1 3 8 1 1 1 
143 KM241 Canine Switzerland 73 2 13 19 2 1 1 3 2 
144 8.2211 Canine USA, TN 92 1 8 1 2 6 2 3 1 
145 06.1705a Canine USA, TN 96 1 32 23 3 1 1 3 1 
146 07.367C Canine USA, TN 97 1 8 1 1 7 2 2 1 
147 8.1781 Canine USA, TN 99 1 27 8 2 5 3 5 2 
148 7.1447 Canine USA, TN 100 2 7 1 3 1 2 5 1 
149 NA 31 Canine USA, WA 100 2 7 1 3 4 3 10 1 
150 07.182a Canine USA, TN 101 2 8 1 1 4 2 3 1 
151 8.1721 Canine USA, TN 102 2 8 2 2 6 2 2 1 
152 06.2735a Canine USA, TN 103 2 9 1 3 8 1 3 1 
153 07.188a Canine USA, TN 103 2 9 1 3 4 2 4 1 
154 8.1791 Canine USA, TN 103 2 9 1 3 8 1 3 2 
155 07.169a Canine USA, TN 104 2 9 2 3 8 1 1 1 
156 7.5066 Canine USA, TN 105 2 10 1 1 2 2 2 1 
157 2.09E+09 Canine Netherland 106 2 13 1 2 4 4 3 2 
158 2.081E+09 Canine Netherland 106 2 13 1 2 4 4 3 2 
159 V0708754 Canine Netherland 106 2 13 1 2 4 4 3 1 
160 06.2381a Canine USA, TN 107 2 13 1 3 10 2 9 1 
161 07.281a Canine USA, TN 108 2 13 1 4 9 3 1 3 
162 06.3998a Canine USA, TN 109 2 27 1 1 8 2 1 1 
163 07.257a Canine USA, TN 110 2 27 1 2 3 2 3 4 
164 V0805157 Canine Netherland 111 2 7 1 4 4 4 3 2 
165 V0709390-3 Canine Netherland 114 1 7 4 3 4 1 3 1 
166 NA  11 Canine USA, TX 118 2 7 11 2 5 2 2 2 
167 NA 12 Canine USA, TX 118 2 7 11 2 5 2 2 2 
168 NA 67 Canine USA, CA 159 1 2 8 3 1 2 2 1 
169 NA 55 Canine USA, CA 71 1 9 2 1 1 1 6 2 
170 NA 23 Canine Canada 71 1 9 2 1 1 1 6 2 
171 NA 47 Canine USA, WI 800 
          
New         
7 1 1 4 3 3 1 
172 NA  20 Canine Canada 900 2 
        
New 
1 2 1 1 3 1 
173 NA 85 Canine USA, IN 158 2 9 1 4 3 2 1 1 
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Table 2.3. Continued 
    MLST-8 




ST tuf cpn60 pta agrD purA Fdh pfoR sar 
Origin 
 
174 8.1748 Canine USA, TN 157 1 27 1 2 11 1 4 1 
175 08.3174a Canine USA, TN 156 2 13 4 1 3 1 3 1 





































The origin of methicillin resistance among S. pseudintermedius is unknown. The 
geographical concentration of two clonal populations in Europe and North 
America, ST 71 and ST 68 suggest recent acquisition of the mecA gene. [6, 7, 
57]. These observations were dependent on studies with restricted interpretation 
because only four alleles were used for genetic analysis and the geographic 
areas sampled were limited. In the current study five of the nine MRSP lineages 
were further divided with the use of an expanded panel of alleles. Since a low 
number of MRSP were used to establish the MLST scheme it is likely that many 
of the MRSP clones will be further divided when this method is applied in 
population studies.  
 
The highest degree of polymorphism among the four genes studied occurred in 
the purA gene locus and it seems to contain four distinct phylogenetic lineages. 
purA allele 1 was present in a majority of the MRSP tested and may have a 
selective advantage, however, almost all predicted purA products had the same 
amino acid sequences as the one encoded by allele 1. The house keeping 
functions of purA, fdh, and sar gene products may be essential for bacterial 
survival and thus there are likely restrictions on their amino acid composition. 
The fdh gene encodes proteins involved in the oxidation of formate to 
bicarbonate and all the mutations in fdh were silent. sar gene products encode 
proteins involved in substrate uptake and the accumulation of small solutes 
within the cell. The polymorphisms in sar were silent except for one sense 
mutation. pfoR gene is similar in sequence to a gene encodes a protein involves 
in the regulation of the perfringolysin 0 (theta-toxin) gene in Clostridium 
perfringens. The function of pfoR in S. pseudintermedius is unclear. Most of the 
pfoR polymorphisms were silent except for one that caused premature 
termination of the protein by the formation of a stop codon at amino acid 131 in 
the deduced protein. The alleles used for MLST belong to genes that are intrinsic 
to S. pseudintermedius. Such housekeeping genes with high polymorphism 
represent ideal and reliable alleles for MLST of S. pseudintermedius to be used 
in combination to previously used 4 alleles[98]. 
 
The proposed MLST scheme identified 106 unique sequence types, 23 more 
than had been previously recognized. Thus, it has improved discriminatory ability 




The  origin of emerging strains is often studied by the use of eBURST analysis 
[101]. This method of analyzing MLST data has been used for the identification of 
founder strains and to obtain an overview of population dynamics. Due to the 
high diversity of the isolates used in this study and the large number of alleles  
and connecting a large number of strains. Data from a broader sampling of 
strains will be required to make this comparison with the higher stringency 
scheme.  
 
MST analysis suggests ST 26 is a founder at the center of each radiating branch. 
The numbers of ST 26 isolates characterized in this study were small and all 
were methicillin-resistant. It is unlikely that methicillin resistance arose prior to the 
expansion of S. pseudintermedius as acquisition of resistance is a fairly recent 
event. Therefore, it is possible that a methicillin-susceptible precursor ST 26 
isolate served as a founder and that methicillin resistance was acquired more 
recently in this ST by lateral transfer. Frequency of ST occurrence was not 
included in the analysis because an appropriate dataset that reflects unbiased 
sampling of a broad population is not currently available. 
 
In this study, we report the development of an 8 loci MLST scheme for S. 
pseudintermedius. We propose that data generated by this method can be 
globally shared to obtain clearer picture of the evolution of methicillin resistance 
among S. pseudintermedius and improve our understanding of the population 
genetics of this species. The new ST identifiers used for the expanded MLST 
scheme are intended only to illustrate relationships within this study. Vincent 
Perreten(vincent.perreten@vbi.unibe.ch) serves as curator for assignment of STs 
for the S. pseudintermedius research community and has generously agreed to 
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Abstract 
 
Little is known about the immune response to S. pseudintermedius, the important 
canine pathogen that has developed a high prevalence of methicillin resistance. 
Understanding the nature of the protective immune response would facilitate the 
design of new therapeutics. The aim of this study was to characterize the nature 
of the immunoglobulin G (IgG) response in 14 dogs with pyoderma and 14 
healthy dogs with no history of pyoderma to antigens from 5 genetically distinct 
S. pseudintermedius isolates and 5 different staphylococcal species. Serum 
samples were obtained at the time of patient admission and 3 to 8 weeks later. 
The staphylococcal proteins were analyzed using three techniques; western blot, 
flow cytometry and Enzyme-Linked ImmunoSorbant Assay (ELISA). The results 
indicated significant differences in the protein banding pattern between the five 
different S. pseudintermedius isolates as revealed by western blot. All 28 dogs 
showed IgG reactivity to multiple S. pseudintermedius antigens. Antibodies to 
some antigens were seen only in samples from infected dogs. The IgG response 
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was correlated in part with the outcome of infection, suggesting the potential 
protective nature of this response. Some variations were shown in the reactivity 
of the five isolates with the dog sera in both groups using flow cytometry which 
indicated a significant difference in the surface exposed antigens between 
different genetic backgrounds. The highest reactivity was to a methicillin-
susceptible clinical isolate of ST96 and to the isolate of ST 71 that represents a 
methicillin-resistant clone widely distributed in Europe. The result was confirmed 
with ELISA. Among the other staphylococcal species tested, S. delphini had least 




A major challenge for healthcare in the Twenty-first century is increasing levels of 
resistance to antimicrobial compounds by some pathogenic bacteria. Multi-drug 
resistance emerged recently as a problem in the important canine bacterium S. 
pseudintermedius [6, 57, 98, 102]. Considering that treatment options in 
veterinary medicine are limited, an effective vaccine to prevent infections is 
urgently needed. 
 
Work with the human pathogen S. aureus has demonstrated the potential 
challenges of developing a vaccine for staphylococci. S. aureus is equipped with 
multiple virulence and immune escape factors, in addition to the genetic 
heterogeneity of the species. Two S. aureus strains can differ by up to 20% of 
their genome, even when they share the core genome. The variable genome 
consists of mobile genetic elements (MGE), such as pathogenicity islands and 
phages, which encode numerous secreted virulence factors, including toxins, 
exoenzymes and immune modulators [103-105]. In addition to genome diversity, 
there are remarkable strain differences in the regulation of gene expression 
resulting in pronounced heterogeneity of S. aureus at the protein level. Protein 
variability is particularly obvious in the extracellular and cell surface proteomes, 
which directly contact the host immune system [106, 107]. From the two available 
S. pseudintermedius genomes [23, 24] there are numerous putative virulence 
factors; however the association between these factors and pathogenesis is 
unclear.  A clearer understanding of the features of the host immune response 
that is necessary for the generation of protective immunity is needed. 
  
The innate immune response to staphylococci is mediated mainly by 
polymorphonuclear leukocytes (PMNs or neutrophils). Phagocytosis of bacteria 
by neutrophils triggers production of reactive oxygen species (ROS) and release 
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of microbiocidal granule components into phagosomes. Although neutrophils are 
effective, some bacteria like S. aureus resist their bactericidal effect by changing 
gene expression to enhance survival of the bacterium. Voyich et al., studied S. 
aureus-PMN interactions using strains isolated from community acquired (CA) 
and hospital acquired (HA) infections and found that genes involved in capsule 
synthesis, gene regulation, oxidative stress, and virulence, were up-regulated 
following ingestion of the pathogen. Phagocytosis of strains from CA infections 
induced changes in gene expression not observed in other strains [108].  
 
 Immunoglobulin G (IgG) plays an essential role in the humoral immune system 
for the control of bacterial infections [109].  One of the important functions of this 
antibody is opsonizing bacteria and improving their recognition by phagocytic 
leukocytes [110]. IgG can also activate the classical complement pathway 
leading to additional opsonization by the complement C3b/iC3b fragments, the 
formation of membrane attack complex and the generation of anaphylatoxins 
[109, 111-114]. 
 
S. aureus utilizes multiple strategies to evade IgG-mediated immune functions. 
S. aureus protein A is a cell-wall protein that binds IgG via the Fc region, thereby 
affecting its ability to act as an opsonin [71]. Some S. aureus isolates also 
modifies humoral host defenses by cleaving IgG that has bound to the bacterial 
surface, thereby inhibiting opsonophagocytosis [115]. Recently it was shown that 
staphylococcal proteases are responsible for the IgG cleavage. Serine protease 
inhibitors and cysteine protease inhibitors decreased the cleavage of surface-
bound IgG resulting in increased complement activation and increased 
phagocytosis efficiency [116]. 
 
It is not clear whether the IgG response to S. aureus is sufficiently protective. As 
was recently shown using a set of eight S. aureus antigens, patients with a fatal 
course of S. aureus bacteremia had lower initial serum antibody concentrations 
than patients who recovered  [117]. However, there was a  pronounced 
heterogeneity in antibody levels against 19 S. aureus antigens among both 
healthy individuals and patients with different S. aureus infections [26]. In a 
different study, the antibody response following S. aureus bacteremia was 
followed in fifteen bacteremic patients and S. aureus isolates were typed by 
PFGE. Genes encoding 19 staphylococcal proteins were detected by PCR and 
the levels of IgG, IgM and IgA for those antigens were determined. It was found 
that isolates of S. aureus were not genetically related and each bacteremic 
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patient developed a unique immune response directed to different staphylococcal 
proteins [86]. 
 
 Although S. aureus has not traditionally been considered an intracellular 
pathogen, its ability to enter and survive within phagocytic and non-phagocytic 
cells is now well established [118-121]. Intracellular survival as small colony 
variants may contribute to persistence of S. aureus in certain pathological 
conditions, such as endocarditis, osteomyelitis, and bovine mastitis [122]. 
Internalization and survival of S. aureus may explain why the humoral immune 
response alone is inefficient and why antibiotic treatment fails to eliminate this 
pathogen, which is well adapted to its host. 
 
The immune response to S. pseudintermedius is largely an unexplored area, 
knowing the nature of the protective immune response to this pathogen may 
facilitate the design of new therapeutics especially after the emergence of 
antibiotic resistance. The objectives of this study are to examine the humoral 
immune response to S. pseudintermedius and to determine the patterns of 
antigen recognition by IgG from dogs with or without pyoderma. Levels of serum 
IgG antibody activity against S. pseudintermedius isolates of different genetic 
backgrounds ( ST 68, ST 71, ST 26, ST 96 and ST 103) were determined with 
sera from canine healthy controls and patients with pyoderma. Serum IgG was 
tested for reactivity with antigens extracted from the following staphylococcal 
species: S. aureus, S. intermedius, S. delphini, S. schleiferi subsp. schleiferi, S. 
schleiferi subsp. coagulans and from S. pseudintermedius isolates of different 
sequence types. S. pseudintermedius isolates were examined for evidence of 
IgG protease and protein A activity.  
 
Materials and Methods 
 
Bacterial isolates and antigen preparation 
 
Clinical isolates of S. aureus, S. delphini, S. schleiferi subsp. schleiferi, S. 
schleiferi subsp. coagulans, and S. pseudintermedius from dogs and a reference 
strain of S. intermedius were used in this study. S. pseudintermedius isolates 
were of the following sequence types: ST 68, ST 26, ST 71, ST 96, and ST 103  
as  previously characterized using MLST-8 ( unpublished data) [7]. Bacterial 
isolates were clonally purified by streaking on Columbia Agar (BD, Sparks, MD) 
containing 5% sterile defibrinated sheep blood (Hemostat, CA). A single, well-
isolated colony from each isolate was inoculated into 5 ml of Nutrient Broth 
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(Difco, France) and incubated at 37˚ in a rotary shaker at 220 rpm.  Whole cell 
lysates were prepared from overnight cultures. The broth cultures were 
centrifuged at 10,000g for 6 m. The supernatant was discarded and the pellets 
were washed twice in sterile phosphate buffered saline PBS (pH 7.2). The pellets 
were suspended in an equal volume of sterile PBS. An equal volume of sample 
lysis buffer (4% SDS, 20% glycerol, 10% 2- mercaptoethanol, 0.004% 
bromophenol blue. pH 6.8, Sigma, Germany) was added, mixed and incubated at 
100°C for 5 m. The tubes were centrifuged at 10,000g for 10 m. The 




 Fourteen client-owned dogs with superficial pyoderma diagnosed by the 
University of Tennessee veterinary dermatology service were enrolled in this 
study.  Dogs were excluded from the study if they were receiving 
immunosuppressive or immunomodulatory medications (including 
corticosteroids, cyclosporine, or cytotoxic agents), if they were systemically ill, or 
if they had a confirmed or suspected diagnosis of neoplasia or an uncontrolled 
endocrinopathy (including hypothyroidism and hyperadrenocorticism).  
Superficial pyoderma was diagnosed by compatible clinical lesions (papules, 
pustules, crusts, and/or epidermal collarettes) and skin cytology findings 
(inflammatory cells, intra- and/or extracellular bacterial cocci). Skin cultures were 
also performed from clinical lesions for isolation of causative organisms and 
susceptibility testing. A full physical examination was performed on each dog and 
the extent of the skin lesions was noted and recorded.  Dogs with skin lesions 
affecting less than 25% of a single body area were noted as having localized 
pyoderma, while those with skin lesions affecting >25% of a single body area or 
multiple body areas were noted as having generalized pyoderma.  For each 
affected dog, the primary disease diagnosis was recorded, as well as any 
medications (other than routine flea and heartworm preventives) that the dog was 
receiving at the time of diagnosis and whether the pyoderma was recurrent (at 
least one previous known infection).  All dogs with pyoderma were treated with 
topical and/or systemic antimicrobials prior to the second examination; all 
treatments were also recorded. 
 
Sixteen healthy control dogs, owned by students, faculty, and staff of the 
University Of Tennessee College Of Veterinary Medicine, were also enrolled in 
the study.  Control dogs had no history of dermatologic or systemic disease, 
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normal physical examinations, and were not receiving medications other than 
routine flea and heartworm preventives. 
 
For all dogs, two blood samples of 4 mls each were collected by jugular 
venipuncture.  For affected dogs, the first blood sample was collected at the time 
of diagnosis.  The owners were asked to return with their dog in one month’s 
time, following antimicrobial therapy in dogs with pyoderma, for collection of the 
second blood sample.  At this time, the affected dogs were examined by a 
member of the dermatology service for clinical and cytologic confirmation of 
pyoderma resolution. For all blood samples, sera was separated and frozen until 
used. 
All procedures were approved by the University of Tennessee Institutional Animal 
Care and Use Committee. 
 
Determination of the immune response 
 
Flow cytometry analysis 
 
An overnight culture was prepared by inoculation of 5 ml nutrient broth (Difco, 
France) with a single colony of S. aureus, S. delphini, S. Schleiferi coagulans, S. 
Schleiferi, S. pseudintermedius isolates belonging to ST 68, ST 71, ST 26, ST 96 
ST, ST 103 and S. intermedius (ATCC 29663). Bacteria were centrifuged and 
pellets were washed with 5 ml PBS. After centrifugation bacteria were 
resuspended in flow buffer (3 ml fetal bovine serum, 60 ml of 0.5% sodium azide 
and 87 ml of PBS) and adjusted to optical density of 2.6 (+- 0.1 OD) at 
wavelength 550 nm. One ml of the suspension was mixed with diluted serum 
samples (1:100) and incubated for 1 hour at 4°C. The bacterial cultures were 
washed with 5 ml PBS and the pellets were suspended in affinity purified FITC 
conjugated anti-dog immunoglobulin G (Bethyl, USA) diluted 1: 500 in PBS and 
incubated for one hour at 4°C. The bacteria were washed with 5 ml PBS and the 
pellets were suspended in 1 ml PBS for analysis. A Beckman Coulter Epics XL 
flow cytometer with EXPO 32 software was used.  
To determine if there was any difference between cultures in logarithmic and 
stationary phases, bacteria were cultured in nutrient broth and incubated in a 
shaking incubator for 5 hours and overnight. Bacteria were centrifuged and 
pellets were washed with 5 ml PBS. Bacteria were resuspended in flow buffer 





Western blot analysis 
 
Western blots were used to assess the reactivity of antibodies with antigen 
extracts of various bacterial species. The whole cell lysates of each clinical 
isolate were resolved by running in SDS-PAGE in 10% polyacrylamide gels (Bio 
Rad, USA) with running buffer containing 0.025 M Tris, 0.192 M Glycine and 
0.1% SDS. Proteins were electrophoretically transferred onto nitrocellulose 
membrane (NC) (Thermo scientific, USA). The transfer was carried out under 
standard conditions, and the resulting blot blocked overnight with 5% (w/v) nonfat 
dried milk powder in phosphate buffered saline containing  Tween-20 (PBS-T - 
PBS, 0.1% Tween 20, pH 7.6) at 4°C. Western transfer buffer contained 0.025M 
Tris, 0.192M Glycine, and 20 % (v/v) methanol. The membranes were washed 
three times for 10 min each using PBS-T at 25°C. The blocked membranes were 
incubated with serum (diluted 1:100) in milk (PBS-T) for 60 min on a horizontal 
rotatory shaker at room temperature (RT). Membranes were washed three times 
as described above. Horseradish peroxidase-conjugated goat anti-dog 
immunoglobulin G secondary antibody (Bethyl, USA) was used at a dilution of 
1:500 in milk PBS-T for 60 min at RT, followed by three washes as described 
above. The reactivity was visualized by exposure to 4- chloro-1-naphthol 
substrate (Thermo scientific, USA). The blots were dried and photographed. 
Western blotting was performed in 10 separate experiments using 5 sera from 
each group (pyoderma and healthy control).   
  
For characterization of the serological response to antigens from each bacterial 
species whole cell lysates of the bacterium were resolved by SDS-PAGE in 10% 
polyacrylamide preparative gels and transferred onto NC membrane. After 
transfer, the NC membrane was cut vertically into strips, which were washed 
twice in PBS and soaked in blocking buffer containing 5% (w/v) nonfat dried milk 
powder in PBS- T overnight at 4ºC. Sera were diluted 1:100 in milk PBS-T and 
added to individual strips. After incubation for an hour at RT in horizontal rotatory 
shaker, the strips were washed with three changes of PBS-T for 10 m each. 
Horseradish peroxidase-conjugated goat anti-dog immunoglobulin G secondary 
antibody (Bethyl, USA) was diluted 1: 500 in milk PBS-T was added to each strip 
and incubated for another hour at 37ºC. Following three washings for 10 min 
each.  The reactivity of the strips was developed by soaking for 5 m in substrate 









Overnight cultures were prepared by inoculation of a single colony in 50 mL of 
sterile tryptic-soy broth (Becton Dickinson, Germany) for each isolate. The broth 
was incubated at 37°C for 24 hours. The cultures were then centrifuged at 4000 
rpm for 10 minutes, 20 mL of PBS were added to the pellets and the pelleted 
bacteria were vortexed to resuspended and wash. The bacterial tubes were 
centrifuged at 4000 rpm for 10 minutes, the pellets were then suspended in 
carbonate/bicarbonate buffer (0.2 M Sodium carbonate bicarbonate, pH = 9.4), to 
an optical density of 1.0 at 550 nm. Hundred uL were pipetted into each well of a 
96 well microtiter plate for coating. The plate was placed at 4°C overnight. The 
plate was washed three times with a plate washer (ELx 405 Biotech Instrument, 
USA) using PBS-T. A 1:100 dilution of serum in PBS-T (from patients or control 
animals) was prepared and 200 uL were added to each well. Serum from each 
time point was run in duplicate, and two control wells were left blank. Serial two-
fold dilutions were prepared up to 1:800, and the ELISA plate was then placed in 
a 37°C incubator for 1 hour. The plate was again washed in the plate washer 
using PBS-T. Horseradish peroxidase-conjugated goat anti-dog immunoglobulin 
G secondary antibody (Bethyl, USA) was used at a dilution of 1:500 in PBS-T 
and 100 uL were added to each well including the two control wells. The plate 
was then incubated for 1 hour at 37°C. The plate was again washed using PBS-
T. Hundred uL of TMB (3,3',5,5'-tetramethylbenzidine) was then added to each 
well.. After 5 minutes, the reaction was stopped using 100 uL per well of stop 
solution (0.18 M sulfuric acid). The absorbance at 450 nm was measured, using 
a plate reader (ELx 800 Biotech instrument, USA).  
 
Determination of expression pattern of proteases and their effect on the 
IgG response 
 
S. pseudintermedius was inoculated into tubes containing 5 ml of nutrient broth. 
Cultures were incubated for 5 hours and overnight at 37°C (for logarithmic and 
stationary phase of growth, respectively) and bacteria were pelleted. 
Supernatants were collected and concentrated by using Microcone filter cut-off 
size 3,000 daltons (Millipore, USA). The filters were centrifuged for 5 min at 3000 
rpm, The concentrated supernatant was washed 2 times with 2ml PBS and 
centrifuged for 2 min at 1000 rpm. To determine if the concentrated S. 





1- Quanti-Cleave protease assay kit (Thermo scientific, USA) was used. 
Procedures were done according to the manufacturer’s instructions, briefly, 100 
µl of succinated casein were placed in a set of wells in a microtiter plate 
(unknown samples and positive control), and 100 µl of assay buffer were placed 
in blank wells. 50 µl of supernatants were added to the sample and the 
corresponding blank well. 50 µl of trypsin at a concentration of 0.5 mg/ml were 
added to a set of wells to serve as a positive control. The plate was incubated at 
37°C for 20 min. 50 µl of the supplied BSAM working solution were added to 
each single well. The plate was incubated at 37°C for 20 min. The color 
absorbance was read at 450 nm. 
 
2- Zymogram SDS 
  
Procedures were done according to the manufacturer’s instructions (Bio-Rad, 
USA). Briefly, one part of the sample was mixed with two parts of Zymogram 
sample buffer, after vortexing, 20 µl of each sample and trypsin (positive control) 
were applied and electrophoresed in 1 x Tris-Glycine SDS running buffer 
according to standard running conditions. After running the gel was incubated 
with 1x Zymogram renaturing buffer with gentle agitation for 30 minutes at RT. 
Zymogram renaturing buffer was decanted and equilibrated with 1x Zymogram 
developing buffer for 30 minutes at RT then replaced with fresh 1x Zymogram 
developing buffer and incubated for at least 4 hours at 37°C. The gel was stained 
with 0.5% comassi blue (w/v in 40% methanol and 10% acetic acid) for 1 hour. 
Gels were destained with 40% methanol, 10% acetic acid and 50% water. Gels 




Determination of putative protein A activity in S. pseudintermedius 
 
S. pseudintermedius isolates ST 68, ST 71, ST 26, ST 96 and spa positive S. 
aureus isolate (ATCC 12598) were cultured in nutrient broth overnight at 37°C. 
Bacteria were centrifuged and pellets were washed with 5 ml PBS. After 
centrifugation bacteria were resuspended in flow buffer and adjusted to optical 
density of 2.6 (+- 0.1 OD) at wavelength 550 nm. The bacterial pellets were 
mixed with 100 µl of 10 fold serial dilutions of canine IgG (Innovative, USA). The 
samples were incubated at 37°C for 30 minutes. Pellets were washed with 5 ml 
PBS. After centrifugation, the pellets were suspended in 25 µl affinity purified 
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FITC conjugated anti-dog immunoglobulin G (Bethyl, USA) diluted 1: 500 in PBS 
and incubated for one hour at 4°C. The mix was washed with 5 ml PBS and the 







Flow cytometry and ELISA data were analyzed as a three factor ANOVA: one 
fixed factor (treatment) and two within-subjects factors (time and antigen type). 





Affected and Control Dog Demographics 
 
Dogs with pyoderma represented 7 different breeds and mixed breeds.  The 
breed make-up was as follows: mixed breed, 4/14 (29%); Labrador Retriever, 
3/14 (21%); Dachshund, 2/14 (14%); Golden Retriever, 1/14 (7%), Boykin 
Spaniel, 1/14 (7%), Miniature Schnauzer, 1/14 (7%) Havanese, 1/14 (7%), 
Cocker Spaniel, 1/14 (7%). Ten of 14 (71%) of dogs with pyoderma were spayed 
females, while 2/14 (14%) each were castrated males and intact females, 
respectively.  Affected dogs ranged in age from 2 years to 12 years, with a 
median age of 5 years and a mean age of 5.8 years.  The most common primary 
disease diagnosis was allergic dermatitis (including flea allergy dermatitis, atopic 
dermatitis, or cutaneous adverse reaction to food), representing 13/14 (93%) 
dogs, while one dog had an unknown primary disease.  One of the 14 dogs had 
concurrent diagnoses of flea allergy dermatitis and generalized demodicosis, 
while 2/14 dogs had concurrent diagnosises of allergic dermatitis and well-
controlled hypothyroidism.  
  
Twelve of 14 (86%) dogs were diagnosed with generalized superficial pyoderma, 
while 2/14 (14%) were diagnosed with localized superficial pyoderma.  Methicillin 
susceptible S. pseudintermedius (MSSP) was isolated on skin culture from 11/14 
(79%) dogs, while methicillin resistant S. pseudintermedius was isolated from the 
skin lesions of 2/14 (14%) dogs.  Mixed isolates of MSSP, methicillin susceptible 
S. schleiferi subsp. coagulans, and Pseudomonas aeruginosa were isolated from 
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skin lesions of one dog.  Two of 14 (14%) affected dogs were treated with 
systemic antimicrobials alone, while 2/14 (14%) dogs (both with localized 
pyoderma) were treated with topical antimicrobials alone, and 11/14 (79%) were 
treated with a combination of topical and systemic antimicrobial therapy.  
Affected dogs were re-examined and the second blood sample was drawn 21-59 
days following the initial examination, with a mean of 37 days between the first 
and second blood collections. The pyoderma was clinically resolved in 9/14 
(64%) dogs at the second time point and was unresolved in 5/14 (36%) dogs.  In 
two of these 5 dogs (40%), MRSP was isolated on skin culture.  One of 5 dogs 
(20%) with unresolved pyoderma at re-examination was initially diagnosed with 
localized infection; all other dogs with unresolved lesions had generalized 
pyoderma.  Ten of 14 (71%) dogs had recurrent pyoderma, while 4/14 (29%) did 
not.  In four of 5 (80%) dogs with unresolved pyoderma, the pyoderma was also 
recurrent. 
Healthy control dogs represented 6 different breeds and mixed breed dogs.  The 
breed make-up was as follows: mixed breed, 8/16 (50%); Pomeranian, 2/16 
(12.5%); Australian Cattle Dog, 2/16 (12.5%); Dachshund, 1/16 (6%); Cocker 
Spaniel, 1/16 (6%); Border Collie, 1/16 (6%); Labrador Retriever, 1/16 (6%).  Ten 
of 16 (62.5%) control dogs were castrated males, while 6/16 (37.5%) were 
spayed females.  Healthy dogs ranged in age from 1 year to 12 years, with a 
median age of 6 years and a mean age of 5.6 years.  The second blood sample 
was drawn from healthy dogs 29-63 days following the initial sampling, with a 
mean of 38 days between the first and second blood samplings. 
 





The three way- interactions (treatment, time and antigen types) were significant, 
by splitting off the three factors interactions: there was a significant difference 
between antigen types in the patient group and time had an effect. Table 3.1 
shows how the pattern of mean differences between antigen types differed 
between time 1 and time 2 within the patient group. ST 96 had the highest 
arithmetic mean which was not significantly different from ST 71. In the control 
group, there was no effect of time. The only difference was the antigen type, the 
highest reactivity was found in ST 96 followed by S. intermedius, ST 71 and S. 




S. aureus isolate (ATCC 12598) served as a positive control for the detection of 
putative spa-like receptor mediated binding of IgG by one or more functionally 
similar protein in S. pseudintermedius. There was no obvious activity for putative 
protein A in S. pseudintermedius (Figure 3.1) 
 
 
Table 3.1 Reactivity of canine IgG with staphylococcal antigens in the 
patient group as determined using flow cytometry.  
 
 
TIME Type of antigen   
N. of 
Observation 
Mean Std Dev 
1 ST68 14 29.0000 DE* 12.1465 
  ST 71 14 65.2857 AB 22.2691 
  ST 26 14 58.3571 BC 29.8422 
  ST 96 14 94.3571  A 43.0681 
  ST 103 14 25.6429  E 15.3503 
  S. aureus 14 42.0000 CD 25.5945 
  S. intermedius 14 50.4286 BC 27.2643 
  S. delphini 14 6.0000 G 6.3851 
  S. sch. schleiferi 14 11.3571 F 6.4879 
  S. sch. coagulans 14 44.6429 CD 28.5862 
2 ST68 14 25.5000 CD 13.9931 
  ST 71 14 39.5714 BC 26.1702 
  ST 26 14 27.0714 CD 12.9167 
  ST 96 14 51.0000 A 46.2551 
  ST 103 14 37.0000 BC 17.2091 
  S. aureus 14 36.1429 BC 13.8334 
  S. intermedius 14 23.0714 D 16.657 
  S. delphini 14 11.7857 E 5.632 
  S. sch. schleiferi 14 10.9286 E 3.8323 
  S. sch. coagulans 14 45.3571 AB 22.4589 
 
 
*Means in the same letter group are not significantly different at P value of 0.05 
In the first time point: 
ST 96 was the highest reactive and ST 71 was the second most reacting ST with 
no significant difference between them. ST 26 and S. intermedius were highly 
reacting and they were not significantly different from ST 71. S. sch. coagulans 
and S. aureus were not significantly different from ST 26 and S. intermedius. ST 
68 was not significantly different from S. aureus and S. sch. coagulans. ST 103, 
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S. sch. schleiferi and S. delphini were the least reactive respectively and they 
were significantly different from each other. In the second time point: 
Reactivity in the second time point was significantly different from the reactivity in 
the first time point. ST 96 was the highest reactive followed by S. sch. coagulans 
and there were no significant difference. ST 71, ST 103 and S. aureus were 
highly reactive and not significantly different from each other and from S. sch. 
coagulans. S. sch. Schleiferi and S. delphini were the least reactive respectively 
and they were not significantly different from each other. 
 
Table 3.2: Reactivity of canine IgG with staphylococcal antigens in the 





Mean Std Dev 
 
ST68 
14 22.2500 D* 25.3999 
ST 71 14 37.3571 B 20.2379 
ST 26 14 25.4815 CD 25.7926 
ST 96 14 63.9286 A 47.7089 
ST 103 14 21.6429 DE 20.3401 
S. aureus 14 30.9643 BC 7.1827 
S. intermedius 14 44.6786 B 32.8262 
S. delphini 14 12.2143 F 5.7113 
S. sch. schleiferi 14 14.1429 EF 12.2526 
S. sch. coagulans 14 31.4643 BC 16.8512 
 
*Means in the same letter group are not significantly different at P value of 0.05 
The highest reactive ST was ST 96 and S. intermedius was the second most 
reactive species, there was a significant difference between them. There was no 
significant difference between ST 71, S. sch. subsp. coagulans, S. aureus and S. 
intermedius. There was no significant difference between ST 68, ST 26 and ST 
















Protean A putative activity of  ST 68, ST 26, ST 71,  ST 96 and spa positive S. 




















































Fourteen S. pseudintermedius pyoderma patient sera were reacted against 
whole-cell antigens prepared from different genetic backgrounds (ST 68, ST 71, 
ST 26, ST 96 and ST 103). There was a common set of bands consisting of at 
least 6 immunoreactive antigens ranging from 200 to 20 KD in the 5 genetic 
backgrounds (table 3.3). At least three of them (ranging between 76 to 30 KD) 
were found in sera from both infected and control groups. There were proteins 
reacted with sera in patient group (ranging between 200 to 70 KD) as shown in 




Table 3.3: Number and molecular weight (KDa) of protein bands of the five 




















S. sch.  
Coagulans 
Average Number of bands 14 15 15 17 16 9 6 5 3 



















Mt Wt. of most intense band 102 102 102 102 60 110 80 40  52 
Mt Wt. of 2nd most intense 
band 30 30 200 60 102 60 150  55  40 
Mt Wt. of 3rd most intense 
band 200 35 70 70 200 70 56  62  70 
 
 

















Figure 3.2. Banding patterns of S. pseudintermedius STs and other 
staphylococcal species against patient serum 
 (1) ST 68, (2) St 71, (3) ST 26, (4) ST 96, (5) ST 103, (6) S. intermedius, (7) S. 
aureus, (8) S. schleiferi coagulans and (9) S. schleiferi subsp. schleiferi were 
separated on 10 % poly acrylamide gels and electroblotted onto NC membranes. 
Membranes were probed with pyoderma serum and goat anti-dog immunoglobulin 



































Using antigens prepared from different S. pseudintermedius sequence types (ST 
96, ST 68, ST 71) and S. schleiferi subsp. schleiferi, the three way- interactions 
(treatment, time and antigen types) were non-significant; however the treatment 
by time and the treatment by antigen type interactions were significant. Time had 
no effect in the control group (T1= 0.7439, T2= 0.7612). In the patient group, 
regardless of antigen type, there was a significant difference between time 1 and 
time 2 (T1= 0.9252, T2= 0.8603). In the control group there was no significant 
difference between ST 103, ST 68 and ST 71; however, there was a significant 
difference between S. sch. schleiferi antigens and each of the S. 
pseudintermedius antigens as shown in table 3.4. In the patient group, there was 
a significant difference between all of the antigen types as shown in table 3.3 and 
time had an effect. The highest reactivity was found in ST 71 (T=1.364) followed 
by ST 103 (T= 1.04225) and ST 68 was 0.7388. 
 
 
IgG reactivity to other Staphylococcal antigens 
 
For S. intermedius there were at least 2 immunoreactive antigens (110 and 70 
KD) shared between the 2 species. For S. aureus, There was one main 
immunoreactive antigen (80 KD) (figure 3.2, table 3.3). 
S. schleiferi subsp. coagulans immunoreactive antigens were ranging between76 
to 30 KD and two of them were shared with S. pseudintermedius antigens.  
Antigens prepared from S. schleiferi subsp. schleiferi and S. delphini were not 
reactive with both the healthy and pyoderma sera. The results were confirmed 
with flow cytometry. S. intermedius was the most reactive staphylococcal species 
in the control group and S. aureus was the most reactive species in the patient 
group. S. schleiferi subsp. coagulans was the next most reactive species in both 











Table 3.4: Reactivity of canine IgG with staphylococcal antigens in the two 
time points as determined using ELISA  
 
Treatment type Time 
N. of 
Observation Mean Std Dev 
Control ST103 1 14 0.8345 A* 0.2835 
    2 14 0.8873 A 0.3587 
  ST68 1 14 0.7638 A 0.3263 
    2 14 0.7555 A 0.3523 
  ST71 1 14 0.9030 A 0.261 
    2 14 0.9334 A 0.2541 
  S. sch. schleiferi 1 14 0.4742 B 0.2353 
    2 14 0.4687 B 0.2578 
Patient ST103 1 14 1.0664 C 0.4451 
    2 14 1.0181 D 0.4202 
  ST68 1 14 0.7646 E 0.2503 
    2 14 0.713 F 0.2067 
  ST71 1 14 1.4152 G 0.3837 
    2 14 1.3146 H 0.3533 
  S. sch. schleiferi 1 14 0.4546 I 0.1998 
    2 14 0.3955 J 0.1568 
 
*Means in the same letter group are not significantly different at P value of 0.05 
There was no significant difference between ST 103, ST 71 and ST 68 in the 
control group and they were significantly differed from S. sch. schleiferi. In the 
patient group, there was a significant difference between all the antigens. The 


















The immune response to S. pseudintermedius is poorly understood. Elucidating 
the protective immune response is a fundamental step toward the development 
of immune-therapies to treat and protect from staphylococcal infections. 
Staphylococcal species have complex genomes with heterogeneity in gene 
expression patterns especially among those that encode surface proteins which 
lead to differences in the immune response. That is why some specific genetic 
backgrounds (versus expendable virulence genes are linked to certain diseases 
[72, 123]. There was a heterogeneous antibody  response against S. aureus in 
bacteremia patients which was related to genetic differences in S. aureus 
isolates [124]. This heterogeneity suggests that a protective vaccine should be 
based on multiple components.  
 
The IgG response of 14 dogs with pyoderma and 14 dogs with no history of 
pyoderma to staphylococcal proteins extracted from 5 genetically different S. 
pseudintermedius isolates were studied using three techniques, flow cytometry, 
ELISA and western blot. There were differences in the IgG reactivity between the 
different genetic backgrounds as revealed by the antigen banding pattern in 
western blots. A similar study was published in 2008 [125], antigens were 
extracted from 6 S. intermedius isolates and were reacted with sera from 21 dogs 
with various skin diseases. Homogeneity in the protein banding patterns in both 
comassi staining and western blot was found between the 6 isolates. The 6 
isolates were isolated from cases of pyoderma and otitis media. They were 
identified biochemically and no further genetic characterization was made. These 
isolates were most probably S. pseudintermedius belonging to the same ST. 
A significantly different reactivity between the 5 isolates was found using flow 
cytometry and ELISA. The highest reactivity was found in ST 96 and ST 71. ST 
68 and ST 103 were the lowest reactive STs of S. pseudintermedius.  ST 96 was 
described in a susceptible isolate in the USA and it has the closest genetic 
background to ST 68, the major methicillin resistant clone in the USA.  They 
differ in 3 out of the 8 genes of MLST-8. The difference in reactivity between ST 
96 and ST 68 emphasizes the correlation of genetic background and antibody 
reactivity.       
 
Major differences were found in the IgG response to the other staphylococcal 
species. Reactivity of sera to S. aureus antigens was moderate. Although 
colonization with S. aureus seems to be uncommon among healthy dogs, some 
recent studies highlight the possibility of the transmission of S. aureus between 
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human to dogs [126-129]. Of those, a report showed high prevalence of the 
isolation of MRSA from dogs with household colonized people. The dog isolates 
were indistinguishable from the human isolates suggesting that interspecies 
transmission of MRSA is possible [126]. There is also a possibility of antibody to 
S. pseudintermedius cross-reacting with S. aureus antigens. Some reports 
described surface proteins in S. pseudintermedius with high similarity to those in 
S. aureus [81]. 
 
S. intermedius was the highest reacting staphylococcal species after S. 
pseudintermedius in the control group and it is the closest genome to S. 
pseudintermedius [10]. This reactivity might be due to the expression of similar 
antigens cross-reacting with S. pseudintermedius antibodies. S. schleiferi 
coagulans was the highest reacting staphylococcal species in the patient group 
after S. pseudintermedius and no difference was noted between the first and the 
second blood sample reactivity. This reactivity may be due to previous exposure 
to this bacterium in some of the dogs as it had been isolated from the external 
auditory meatus of dogs suffering from external otitis [130, 131]. Although they 
were reported as phylogeneticaly close species [10], S. delphini is the lowest 
reactive among the staphylococcal species.  
  
The IgG response to S. pseudintermedius seems to correlate with the outcome of 
infection. The pyoderma infection in five of the fourteen patients was not resolved 
at the second blood sample. In those five patients, the IgG level in the second 
time point was lower than the IgG in the first blood sample. In all of the other 
patients, having the same or higher level of IgG response was correlated with the 
resolution of the infection.  
 
Factors associated with the involvement of S. pseudintermedius in infections are 
not fully clear. The ability of S. pseudintermedius to adhere to canine skin is likely 
to be an important factor in the initiation of infection. S. pseudintermedius strains 
were shown to adhere to immobilized fibrinogen, fibronectin and cytokeratin 10 
[81].  They can secrete α, β and γ haemolysins, protease, coagulase, enterotoxin 
and exfoliative toxin [23, 24]. Comparing healthy control to pyoderma patients in 
terms of antibodies against staphylococcal proteins, there was a common 
signature consisting of three low molecular weight proteins expressed 
constitutively regardless of infection. These proteins are considered important 
however, information about whether they are surface exposed is needed. There 
were four proteins expressed only in pyoderma patients including 180 KD protein 
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which may be the same protein which reacted with antibodies to staphylococcal 
fibrinogen-binding proteins sdrD and cifA reported previously [81]. 
 
S. pseudintermedius may differ from S. aureus in some of the mechanisms of 
evasion of the immune system. S. aureus Protein A (spa) has a molecular weight 
of 42 KDa and is able to bind non-specifically to the Fc fragment of IgG of several 
species, including dogs [71]. An equivalent to spa was described in the genome 
of S. pseudintermedius (IgG-binding protein) and used for developing a species-
specific spa typing protocol [45]. Our results indicated the lack of the activity of 
this gene in ST 68 isolates compared to spa positive S. aureus. S. aureus also 
express proteases from the serine type and their role is the degradation of the 
major opsonins: human IgG and human C3b [115]. There is no evidence for this 
activity in S. pseudintermedius. 
  
In this study the immune response to different genetic backgrounds of S. 
pseudintermedius was determined using a uniform group of S. pseudintermedius 
pyoderma patients and a group of healthy controls. The results indicated the 
heterogeneity of the immune response to the various genetic backgrounds in 
both the groups. There was no evidence for proteases activity or spa like activity 
in S. pseudintermedius. More studies are recommended to examine the role of 






















Chapter 4: Conclusions and Application of Findings 
 
Understanding the genomic diversity is a fundamental step toward understanding 
the immune response to a bacterium and the identification of potential vaccine 
targets. S. pseudintermedius occurs as clonal populations the members of which 
likely share surface antigens. S. pseudintermedius was shown recently with high 
prevalence of methicillin resistance and other antibiotics resistance which limit 
the drug choices to treat S. pseudintermedius infections. In the not too distant 
future there may be few antibiotics to treat such infections. Because of that 
designing a vaccine is a high research priority. 
 
The development of MLST-8 has provided a tool to elucidate the population 
genetics in Staphylococcus pseudintermedius. By using MLST-8, 106 STs were 
analyzed which indicated a high level of genetic diversity of the species which is 
not surprising for a staphylococcal species [132, 133]. Most of this diversity, 
however, is limited to methicillin susceptible isolates. Methicillin resistant isolates, 
on the other hand, are represented by a limited number of highly successful 
clonal types which have apparently spread over wide geographic regions. Once 
MLST-8 is put to use by the S. pseudintermedius research community an even 
better understanding of the clonal nature of S. pseudintermedius and its spatial 
characteristics and population genetics should emerge.  
 
By choosing 5 distinct genetic backgrounds to measure their reactivity against 
pyoderma dog sera and healthy control sera, variations in the immune response 
were found even between two genetically linked STs, ST 68 and ST 96. They 
both are USA isolates and they differ in 3 out of 8 loci. The difference in the 
intensity of the reactivity of the antigens that reacted was significant and the 
reactivity of ST 96 was the highest among S. pseudintermedius and the other 
staphylococcal species. The variation in surface reactivity and banding patterns 
between different genetic backgrounds of S. pseudintermedius suggest that a 
vaccine for S. pseudintermedius may be challenging. Further work, however, 
needs to be done to determine if conserved antigens occur and are shared by 
proteins with different sizes. The ideal candidate would be a conserved surface 
protein, expressed across the different genetic backgrounds and evoke 
protective antibodies. 
 
The differences in antibody reactivity with S. pseudintermedius proteins between 
infected and non- infected dogs were primarily high molecular weight proteins 
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recognized by infected dogs.  Although the identity and function of the proteins is 
unknown they might be virulence factors or immune evasion mediators which 
facilitated clinical disease. For all dogs there was a common set of low molecular 
weight proteins. This is encouraging as they may represent conserved antigens 
which may be suitable as vaccine candidates. Additional testing would be 
required to determine if they are surface exposed. 
 
The reactivity of antigens prepared from different species within the 
Staphylococcus intermedius group (SIG) with dog sera showed that although 
there are minor differences between the genomes of the three members there 
are major differences in the immune reactivity especially between S. 
pseudintermedius or S. intermedius and S. delphini. The former species was 
highly reacting whereas the later was the lowest reacting. Since S. intermedius 
and S. delphini are not associated with canine infections it is likely that the 
antibody reactivity with these species was a cross-reaction with S. 
pseudintermedius immunogens.  
 
In 2010 McCarthy and Lindsay studied the relationship between surface and 
immune evasion gene variation and genetic backgrounds in S. aureus. They 
demonstrated that variation in genes encoding surface proteins and genes 
encoding secreted proteins predicted to interact with host immune responses is 
lineage specific. Most of the variations occurred in predicted functional domains 
and some surface proteins were missed or truncated in some lineages. Some 
domains were found to be conserved across the lineages [132] and they 
concluded that successful staphylococcal vaccines should contain cocktails of 
antigens representing all variants. Our work prepares a foundation for identifying 
representative members of the predominant lineages and candidate antigens to 
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Table 2.1.A.  Allele description of purA gene 
 
PurA nucleotide position 
allele 105 113 174 186 192 258 339 342 367 396 399 
1 T T C G C C T G G T G 
2 T T C T T C T G G T G 
3 T T C T T T C A G C G 
4 T T C T T C T G G C G 
5 C T C G T C T G G C G 
6 T T C G T C T G G C G 
7 T T C G C T T G G C G 
8 C T C G C T T G G C G 
9 T T C G C C T G G C T 
10 C T C G C C T G G C G 
11 T T C T T C T G A C G 
12 T T C G C C C A G C G 
13 T T C G C C T G G C G 
14 T T C G T T C G G C G 
15 T C C G C T T G G C G 
16 C T T G C T T G G T G 
17 T T C T T T T A G C G 
18 C T C G T C T G G T G 
19 C T C G C T T G G T G 


















Table 2.2.A. Allele description of fdh gene 
 
fdh nucleotide position 
allele 19 103 106 112 250 
1 C G C G G 
2 C A T A G 
3 C A T A T 
4 A A T A G 






































pfoR nucleotide position 
allele 51 72 87 93 99 126 281 342 354 372 
1 T T G A G G C A T G 
2 T T G A G G C C C G 
3 T T G A A G C A T G 
4 T T A A G G C C C G 
5 T T G A A G C C T G 
6 T T G G G G C A T A 
7 T T G A G G C C T G 
8 T C G A G G C C C G 
9 T T G A G A C A T G 
10 T T G A A G C C C G 
11 T T G G G G A A T G 
12 T T G A A A C C T G 
13 C T G A A G C C T G 























Table 2.4.A. Allele description of sar gene 
 
 
sar nucleotide position 
allele 43 67 146 208 238 256 341 358 
1 G G C A C C G G 
2 G G C T C C G G 
3 G G C A T C G A 
4 A A C A C C G G 
5 A G C A C C G G 
6 G G C A T C G G 
7 G G C A C C A G 
8 G G T A C T G G 
9 G G C T T C G G 






















Table 2.5.A.  Trimming sequences of the four new genes 
 
Gene                                       Trimming sequences  
 
purA 5'TAT GCA GCT GGT CAA CG 
 3'CGT CGT GTG AGY GGG AT 
  
sar 5'GTT AAA AGG TGA CGA AC 
 3'GAT CAA CTC GTT CAT GA 
  
pfoR 5'AAT GCG GCC ATC GCA CC 
 3'GGG CGA AAC ACC AAT GG 
  
fdh 5'TTC AAT TGA ACC TGA AT 
  






























Table 2.6.A.  The distribution of the alleles of the 4 new genes in 176 isolates 
 
Allele purA fdh pfoR sar 
Allele 1 80 88 63 117 
Allele 2 9 57 28 41 
Allele 3 9 12 38 2 
Allele 4 21 18 10 8 
Allele 5 15 1 8 5 
Allele 6 2  18 1 
Allele 7 8  1 1 
Allele 8 12  3 1 
Allele 9 1  2  
Allele 10 1  1  
Allele 11 1  1  
Allele 12 1  1  
Allele 13 7  1  
Allele 14 3  1  
Allele 15 1    
Allele 16 1    
Allele 17 1    
Allele 18 1    
Allele 19 1    
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